Veterinary Medicines

Equimax oral gel for horses

Authorised
  • Ivermectin
  • Praziquantel
Download as PDF

Product identification

Medicine name:
Equimax oral gel for horses
EQUIMAX
Active substance:
  • Ivermectin
  • Praziquantel
Target species:
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ivermectin
    18.70
    milligram(s)
    /
    1.00
    gram(s)
  • Praziquantel
    140.30
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral gel
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Meat and offal
        35
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:
  • An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 7.49 grams of product and is fitted with variable dose capacity.Product presentations:Box of 48 syringes.
  • An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 7.49 grams of product and is fitted with variable dose capacity.Product presentations:Box of 40 syringes.
  • An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 7.49 grams of product and is fitted with variable dose capacity.Product presentations:Box of 12 syringes.
  • An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 7.49 grams of product and is fitted with variable dose capacity.Product presentations:Box of 2 syringes.
  • An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 7.49 grams of product and is fitted with variable dose capacity.Product presentations:Box of 1 syringe or Blister of one syringe.
  • An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 6.42 grams of product and is fitted with variable dose capacity.Product presentations:Box of 48 syringes.
  • An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 6.42 grams of product and is fitted with variable dose capacity.Product presentations:Box of 40 syringes.
  • An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 6.42 grams of product and is fitted with variable dose capacity.Product presentations:Box of 12 syringes.
  • An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 6.42 grams of product and is fitted with variable dose capacity.Product presentations:Box of 2 syringes.
  • An adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white).The syringe contains 6.42 grams of product and is fitted with variable dose capacity.Product presentations:Box of 1 syringe or Blister of one syringe.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
  • Sofarimex-Industria Quimica E Farmaceutica S.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 103564
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0501/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."